The fetal origins of mental illness

American Journal of Obstetrics and Gynecology

Volumn 221, Issue 6, 2019, Pages 549-562

  al Haddad, Benjamin J S ^a   Oler, Elizabeth ^a   Armistead, Blair ^b,c   Elsayed, Nada A ^d   Weinberger, Daniel R ^d   Bernier, Raphael ^a   Burd, Irina ^d   Kapur, Raj ^b   Jacobsson, Bo ^e,f,g   Wang, Caihong ^h   Mysorekar, Indira ^h   Rajagopal, Lakshmi ^a,c   Adams Waldorf, Kristina M ^b,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autism; brain; depression; fetus; infection; inflammation; influenza virus; microglia; neuronal injury; pregnancy; schizophrenia; seasonality of birth hypothesis; TORCH; urinary tract infection

Indexed keywords

ASTROCYTE; AUTISM; BIPOLAR DISORDER; BRAIN INJURY; CELL ACTIVATION; DEPRESSION; EPIGENETICS; FETUS DEVELOPMENT; GENETIC SUSCEPTIBILITY; HUMAN; MENTAL DISEASE; MICROGLIA; OLIGODENDROGLIA; PLACENTA DISORDER; PLACENTAL INFLAMMATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; ANIMAL; FEMALE; IMMUNOLOGY; INFLAMMATION; METABOLISM; NERVE CELL; NEURAL STEM CELL; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE;

CYTOKINE; SEROTONIN;

ANIMALS; ASTROCYTES; AUTISM SPECTRUM DISORDER; BIPOLAR DISORDER; CYTOKINES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; MENTAL DISORDERS; MICROGLIA; NEURAL STEM CELLS; NEURONS; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; SCHIZOPHRENIA; SEROTONIN;

EID: 85069933788     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2019.06.013     Document Type: Review

References (223)

1. McAlister Gregg, N., Banatvala, R., by, J.E., Congenital cataract following German measles in the mother. Rev Med Virol 11 (2001), 277–285.
2. Yazigi, A., De Pecoulas, A.E., Vauloup-Fellous, C., Grangeot-Keros, L., Ayoubi, J.-M., Picone, O., Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature. J Matern Neonatal Med 30 (2017), 274–278.
3. Cluver, C., Meyer, R., Odendaal, H., Geerts, L., Congenital rubella with agenesis of the inferior cerebellar vermis and total anomalous pulmonary venous drainage. Ultrasound Obstet Gynecol 42 (2013), 235–237.
4. Parisot, S., Droulle, P., Feldmann, M., Pinaud, P., Marchal, C., Unusual encephaloclastic lesions with paraventricular calcification in congenital rubella. Pediatr Radiol 21 (1991), 229–230.
5. Andrade, J.Q., Bunduki, V., Curti, S.P., Figueiredo, C.A., de Oliveira, M.I., Zugaib, M., Rubella in pregnancy: intrauterine transmission and perinatal outcome during a Brazilian epidemic. J Clin Virol 35 (2006), 285–291.
6. Barry, H. III, Barry, H. Jr., Season of birth: an epidemiological study in psychiatry. Arch Gen Psychiatry 5 (1961), 292–300.
7. Hare, E.H., Price, J.S., Slater, E., Mental disorder and season of birth. Nature, 241, 1973, 480.
8. Parker, G., Neilson, M., Mental disorder and season of birth—a southern hemisphere study. Br J Psychiatry 129 (1976), 355–361.
9. Torrey, E.F., Peterson, M.R., The viral hypothesis of schizophrenia. Schizophr Bull 2 (1976), 136–146.
10. Atladóttir, H.Ó., Thorsen, P., Østergaard, L., et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40 (2010), 1423–1430.
11. al-Haddad, B.J.S., Jacobsson, B., Chabra, S., et al. Long-term risk of neuropsychiatric disease after exposure to infection in utero. JAMA Psychiatry, 2019, 594–602.
12. Birnbaum, R., Weinberger, D.R., Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci, 18, 2017, 727.
13. Brown, A.S., Derkits, E.J., Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167 (2010), 261–280.
14. Susser, E.S., Lin, S.P., Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Arch Gen Psychiatry 49 (1992), 983–988.
15. St Clair, D., Xu, M., Wang, P., et al. Rates of adult schizophrenia following prenatal exposure to the Chinese Famine of 1959-1961. JAMA 294 (2005), 557–562.
16. Niemela, S., Sourander, A., Surcel, H.M., et al. Prenatal nicotine exposure and risk of schizophrenia among offspring in a national birth cohort. Am J Psychiatry 173 (2016), 799–806.
17. Abel, K.M., Wicks, S., Susser, E.S., et al. Birth weight, schizophrenia, and adult mental disorder: is risk confined to the smallest babies? Birth weight, schizophrenia, and mental disorder. Arch Gen Psychiatry 67 (2010), 923–930.
18. Wrede, G., Mednick, S.A., Huttunen, M.O., Nilsson, C.G., Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers. Acta Psychiatr Scand 62 (1980), 369–381.
19. Machón, R.A., Mednick, S.A., Schulsinger, F., The interaction of seasonality, place of birth, genetic risk and subsequent schizophrenia in a high risk sample. Br J Psychiatry 143 (1983), 383–388.
20. Watson, C.G., Kucala, T., Tilleskjor, C., Jacobs, L., Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch Gen Psychiatry 41 (1984), 85–90.
21. Tochigi, M., Okazaki, Y., Kato, N., Sasaki, T., What causes seasonality of birth in schizophrenia?. Neurosci Res 48 (2004), 1–11.
22. Mednick, S.A., Machon, R.A., Huttunen, M.O., Bonett, D., Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45 (1988), 189–192.
23. Brown, A.S., Schaefer, C.A., Wyatt, R.J., et al. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull 26 (2000), 287–295.
24. Brown, A.S., Begg, M.D., Gravenstein, S., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61 (2004), 774–780.
25. Brown, A.S., Schaefer, C.A., Quesenberry, C.P., Liu, L., Babulas, V.P., Susser, E.S., Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 162 (2005), 767–773.
26. Brown, A.S., Schaefer, C.A., Quesenberry, C.P. Jr., Shen, L., Susser, E.S., No evidence of relation between maternal exposure to herpes simplex virus type 2 and risk of schizophrenia?. Am J Psychiatry 163 (2006), 2178–2180.
27. Babulas, V., Factor-Litvak, P., Goetz, R., Schaefer, C.A., Brown, A.S., Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry 163 (2006), 927–929.
28. Khandaker, G.M., Zimbron, J., Lewis, G., Jones, P.B., Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med 43 (2013), 239–257.
29. Abib, R.T., Gaman, A., Dargél, A.A., et al. Intracellular pathogen infections and immune response in autism. Neuroimmunomodulation 25 (2018), 271–279.
30. Lyall, K., Croen, L., Daniels, J., et al. The changing epidemiology of autism spectrum disorders. Annu Rev Public Health 38 (2017), 81–102.
31. Jiang, H.Y., Xu, L.L., Shao, L., et al. Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis. Brain Behav Immun 58 (2016), 165–172.
32. Lee, B.K., Magnusson, C., Gardner, R.M., et al. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav Immun 44 (2015), 100–105.
33. Choi, G.B., Yim, Y.S., Wong, H., et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351 (2016), 933–939.
34. Fernández de Cossío, L., Guzmán, A., van der Veldt, S., Luheshi, G.N., Prenatal infection leads to ASD-like behavior and altered synaptic pruning in the mouse offspring. Brain Behav Immun 63 (2017), 88–98.
35. Machado, C.J., Whitaker, A.M., Smith, S.E.P., Patterson, P.H., Bauman, M.D., Maternal immune activation in nonhuman primates alters social attention in juvenile offspring. Biol Psychiatry 77 (2015), 823–832.
36. Malkova, N.V., Yu, C.Z., Hsiao, E.Y., Moore, M.J., Patterson, P.H., Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26 (2012), 607–616.
37. Shin Yim, Y., Park, A., Berrios, J., et al. Reversing behavioural abnormalities in mice exposed to maternal inflammation. Nature 549 (2017), 482–487.
38. Baharnoori, M., Bhardwaj, S.K., Srivastava, L.K., Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: a prenatal infection model for developmental neuropsychiatric disorders. Schizophr Bull 38 (2012), 444–456.
39. Kaidanovich-Beilin, O., Lipina, T., Vukobradovic, I., Roder, J., Woodgett, J.R., Assessment of social interaction behaviors. J Vis Exp, 48, 2011, 2473.
40. Pendyala, G., Chou, S., Jung, Y., et al. Maternal immune activation causes behavioral impairments and altered cerebellar cytokine and synaptic protein expression. Neuropsychopharmacology, 15, 2017, 15.
41. Bergdolt, L., Dunaevsky, A., Brain changes in a maternal immune activation model of neurodevelopmental brain disorders. Prog Neurobiol 175 (2019), 1–19.
42. Careaga, M., Murai, T., Bauman, M.D., Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates. Biol Psychiatry 81 (2017), 391–401.
43. Bauman, M.D., Iosif, A.M., Smith, S.E., Bregere, C., Amaral, D.G., Patterson, P.H., Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol Psychiatry 75 (2014), 332–341.
44. Bölte, S., Girdler, S., Marschik, P.B., The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci 76 (2019), 1275–1297.
45. Modabbernia, A., Velthorst, E., Reichenberg, A., Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol Autism, 8, 2017, 13.
46. Campbell, A., Araujo, J.A., Li, H., Sioutas, C., Kleinman, M., Particulate matter induced enhancement of inflammatory markers in the brains of apolipoprotein E knockout mice. J Nanosci Nanotechnol 9 (2009), 5099–5104.
47. Gerlofs-Nijland, M.E., van Berlo, D., Cassee, F.R., Schins, R.P.F., Wang, K., Campbell, A., Effect of prolonged exposure to diesel engine exhaust on proinflammatory markers in different regions of the rat brain. Part Fibre Toxicol, 7, 2010, 12.
48. Levesque, S., Taetzsch, T., Lull, M.E., et al. Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity. Environ Health Perspect 119 (2011), 1149–1155.
49. Edlow, A.G., Maternal obesity and neurodevelopmental and psychiatric disorders in offspring. Prenat Diagn 37 (2017), 95–110.
50. Godfrey, K.M., Reynolds, R.M., Prescott, S.L., et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol 5 (2017), 53–64.
51. Chen, S., Zhong, X., Jiang, L., et al. Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: a systematic review and meta-analysis. Behav Brain Res 296 (2016), 61–69.
52. Wu, S., Ding, Y., Wu, F., et al. Family history of autoimmune diseases is associated with an increased risk of autism in children: a systematic review and meta-analysis. Neurosci Biobehav Rev 55 (2015), 322–332.
53. Werling, D.M., Parikshak, N.N., Geschwind, D.H., Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders. Nat Commun, 7, 2016, 10717.
54. Voineagu, I., Wang, X., Johnston, P., et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474 (2011), 380–384.
55. Gupta, S., Ellis, S.E., Ashar, F.N., et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun, 5, 2014, 5748.
56. Brown, A.S., Susser, E.S., Lin, S.P., Gorman, J.M., Affective disorders in Holland after prenatal exposure to the 1957 A2 influenza epidemic. Biol Psychiatry 38 (1995), 270–273.
57. Parboosing, R., Bao, Y., Shen, L., Schaefer, C.A., Brown, A.S., Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 70 (2013), 677–685.
58. Machón, R., Mednick, S., Huttunen, M., Adult major affective disorder after prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 54 (1997), 322–328.
59. Canetta, S.E., Bao, Y., Co, M.D.T., et al. Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring. Am J Psychiatry 171 (2014), 557–563.
60. Barichello, T., Badawy, M., Pitcher, M.R., et al. Exposure to perinatal infections and bipolar disorder: a systematic review. Curr Mol Med 16 (2016), 106–118.
61. Simanek, A.M., Meier, H.C.S., Association between prenatal exposure to maternal infection and offspring mood disorders: a review of the literature. Curr Probl Pediatr Adolesc Health Care 45 (2015), 325–364.
62. Du Preez, A., Leveson, J., Zunszain, P.A., Pariante, C.M., Inflammatory insults and mental health consequences: does timing matter when it comes to depression?. Psychol Med 46 (2016), 2041–2057.
63. Brown, A.S., Susser, E.S., Lin, S.P., Gorman, J.M., Affective disorders in Holland after prenatal exposure to the 1957 A2 influenza epidemic. Biol Psychiatry 38 (1995), 270–273.
64. Takei, N., O'Callaghan, E., Sham, P.C., Glover, G., Murray, R.M., Does prenatal influenza divert susceptible females from later affective psychosis to schizophrenia?. Acta Psychiatr Scand 88 (1993), 328–336.
65. Mino, Y., Oshima, I., Okagami, K., Mood disorders and influenza epidemics in Japan. Psychiatry Clin Neurosci 54 (2000), 59–65.
66. Cannon, M., Cotter, D., Coffey, V.P., et al. Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: a follow-up study. Br J Psychiatry 168 (1996), 368–371.
67. Morgan, V., Castle, D., Page, A., et al. Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: no evidence of a major effect. Schizophr Res 26 (1997), 25–39.
68. Pang, D., Syed, S., Fine, P., Jones, P.B., No association between prenatal viral infection and depression in later life—a long-term cohort study of 6152 subjects. Can J Psychiatry 54 (2009), 565–570.
69. Murphy, S.K., Fineberg, A.M., Maxwell, S.D., et al. Maternal infection and stress during pregnancy and depressive symptoms in adolescent offspring. Psychiatry Res 257 (2017), 102–110.
70. Lydholm, C.N., Köhler-Forsberg, O., Nordentoft, M., et al. Parental infections before, during, and after pregnancy as risk factors for mental disorders in childhood and adolescence: a nationwide Danish study. Biol Psychiatry 85 (2019), 317–325.
71. Ronovsky, M., Berger, S., Zambon, A., et al. Maternal immune activation transgenerationally modulates maternal care and offspring depression-like behavior. Brain Behav Immun 63 (2017), 127–136.
72. Majidi-Zolbanin, J., Doosti, M.-H., Kosari-Nasab, M., Salari, A.-A., Prenatal maternal immune activation increases anxiety- and depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis. Neuroscience 294 (2015), 69–81.
73. Reisinger, S.N., Kong, E., Khan, D., et al. Maternal immune activation epigenetically regulates hippocampal serotonin transporter levels. Neurobiol Stress 4 (2016), 34–43.
74. Khan, D., Fernando, P., Cicvaric, A., et al. Long-term effects of maternal immune activation on depression-like behavior in the mouse. Transl Psychiatry Psychiatry, 4, 2014, e363.
75. Arad, M., Piontkewitz, Y., Albelda, N., Shaashua, L., Weiner, I., Immune activation in lactating dams alters sucklings’ brain cytokines and produces non-overlapping behavioral deficits in adult female and male offspring: a novel neurodevelopmental model of sex-specific psychopathology. Brain Behav Immun, 8, 2017, 8.
76. Depino, A.M., Early prenatal exposure to LPS results in anxiety- and depression-related behaviors in adulthood. Neuroscience 299 (2015), 56–65.
77. Ronovsky, M., Berger, S., Molz, B., Berger, A., Pollak, D.D., Animal models of maternal immune activation in depression research. Curr Neuropharmacol 14 (2016), 688–704.
78. Cheeran, M.C., Lokensgard, J.R., Schleiss, M.R., Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 22 (2009), 99–126.
79. Yinon, Y., Farine, D., Yudin, M.H., No. 240-cytomegalovirus infection in pregnancy. J Obs Gynaecol Can 40 (2018), 134–141.
80. Davis, J.O., Phelps, J.A., Bracha, H.S., Prenatal development of monozygotic twins and concordance for schizophrenia. Schizophr Bull 21 (1995), 357–366.
81. Ursini, G., Punzi, G., Chen, Q., et al. Convergence of placenta biology and genetic risk for schizophrenia. Nat Med, 2018, 792–801.
82. Kim, C.J., Romero, R., Chaemsaithong, P., Kim, J.-S., Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol 213:4 Suppl (2015), S53–S69.
83. Lei, J., Rosenzweig, J.M., Mishra, M.K., et al. Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury. Sci Rep, 7, 2017, 6106.
84. Lei, J., Xie, L., Zhao, H., et al. Maternal CD8+ T-cell depletion alleviates intrauterine inflammation-induced perinatal brain injury. Am J Reprod Immunol, 79, 2018, e12798.
85. Abdallah, M.W., Larsen, N., Grove, J., et al. Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry 14 (2013), 528–538.
86. Dammann, O., O'Shea, T.M., Cytokines and perinatal brain damage. Clin Perinatol 35 (2008), 643–663.
87. Letterio, J.J., Geiser, A.G., Kulkarni, A.B., Roche, N.S., Sporn, M.B., Roberts, A.B., Maternal rescue of transforming growth factor-beta 1 null mice. Science 264 (1994), 1936–1938.
88. Lennard, S.N., Stewart, F., Allen, W.R., Transforming growth factor β1 expression in the endometrium of the mare during placentation. Mol Reprod Dev 42 (1995), 131–140.
89. Calhoun, D.A., Gersting, J.A., Lunøe, M., Du, Y., Christensen, R.D., Transfer of recombinant human granulocyte colony stimulating factor (rhG-CSF) from the maternal to the fetal circulation is not dependent upon a functional G-CSF-receptor. Placenta 22 (2001), 609–612.
90. Meyer, U., Feldon, J., Yee, B.K., A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35 (2009), 959–972.
91. Lawrence, S.M., Wynn, J.L., Chorioamnionitis, IL-17A, and fetal origins of neurologic disease. Am J Reprod Immunol, 79, 2018, e12803.
92. Meyer, U., Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75 (2014), 307–315.
93. Ponzio, N.M., Servatius, R., Beck, K., Marzouk, A., Kreider, T., Cytokine levels during pregnancy influence immunological profiles and neurobehavioral patterns of the offspring. Ann N Y Acad Sci, 1107, 2007.
94. Bell, M.J., Hallenbeck, J.M., Gallo, V., Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res, 56, 2004, 541.
95. Liverman, C.S., Kaftan, H.A., Cui, L., et al. Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection. Neurosci Lett 399 (2006), 220–225.
96. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., de Water, J., Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun, 25, 2011.
97. Li, X., Chauhan, A., Sheikh, A.M., et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 207 (2009), 111–116.
98. Masi, A., Quintana, D.S., Glozier, N., Lloyd, A.R., Hickie, I.B., Guastella, A.J., Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry, 20, 2014, 440.
99. Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., Pardo, C.A., Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005), 67–81.
100. Wei, H., Zou, H., Sheikh, A.M., et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation, 8, 2011, 52.
101. Wu, W.L., Hsiao, E.Y., Yan, Z., Mazmanian, S.K., Patterson, P.H., The placental interleukin-6 signaling controls fetal brain development and behavior. Brain Behav Immun 62 (2017), 11–23.
102. Hsiao, E.Y., Patterson, P.H., Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 25 (2011), 604–615.
103. Goeden, N., Velasquez, J., Arnold, K.A., et al. Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brain. J Neurosci 36 (2016), 6041–6049.
104. Bonnin, A., Goeden, N., Chen, K., et al. A transient placental source of serotonin for the fetal forebrain. Nature 472 (2011), 347–350.
105. Muller, C.L., Anacker, A.M., Rogers, T.D., et al. Impact of maternal serotonin transporter genotype on placental serotonin, fetal forebrain serotonin, and neurodevelopment. Neuropsychopharmacology 42 (2017), 427–436.
106. Fan, L.-W., Bhatt, A., Tien, L.-T., et al. Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro. J Neurochem 133 (2015), 532–543.
107. Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H., Iyo, M., Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59 (2006), 546–554.
108. Zuckerman, L., Rehavi, M., Nachman, R., Weiner, I., Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28 (2003), 1778–1789.
109. Bitanihirwe, B.K.Y., Peleg-Raibstein, D., Mouttet, F., Feldon, J., Meyer, U., Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology, 35, 2010, 2462.
110. Vuillermot, S., Joodmardi, E., Perlmann, T., Ove Ögren, S., Feldon, J., Meyer, U., Prenatal immune activation interacts with genetic nurr1 deficiency in the development of attentional impairments. J Neurosci 32 (2012), 436–451.
111. Knuesel, I., Chicha, L., Britschgi, M., et al. Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol, 10, 2014, 643.
112. Reisinger, S., Khan, D., Kong, E., Berger, A., Pollak, A., Pollak, D.D., The poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery. Pharmacol Ther 149 (2015), 213–226.
113. Pratt, L., Ni, L., Ponzio, N.M., Jonakait, G.M., Maternal inflammation promotes fetal microglial activation and increased cholinergic expression in the fetal basal forebrain: role of interleukin-6. Pediatr Res 74 (2013), 393–401.
114. Zeidán-Chuliá, F., Salmina, A.B., Malinovskaya, N.A., Noda, M., Verkhratsky, A., Moreira, J.C.F., The glial perspective of autism spectrum disorders. Neurosci Biobehav Rev 38 (2014), 160–172.
115. Zimmerman, A.W., Jyonouchi, H., Comi, A.M., et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33 (2005), 195–201.
116. Morgan, J.T., Chana, G., Pardo, C.A., et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68 (2010), 368–376.
117. Tetreault, N.A., Hakeem, A.Y., Jiang, S., et al. Microglia in the cerebral cortex in autism. J Autism Dev Disord 42 (2012), 2569–2584.
118. Morgan, J.T., Chana, G., Abramson, I., Semendeferi, K., Courchesne, E., Everall, I.P., Abnormal microglial–neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res 1456 (2012), 72–81.
119. Suzuki, K., Sugihara, G., Ouchi, Y., et al. Microglial activation in young adults with autism spectrum disordermicroglia in young adults with ASD. JAMA Psychiatry 70 (2013), 49–58.
120. Juckel, G., Manitz, M.P., Brüne, M., Friebe, A., Heneka, M.T., Wolf, R.J., Microglial activation in a neuroinflammational animal model of schizophrenia—a pilot study. Schizophr Res 131 (2011), 96–100.
121. Van den Eynde, K., Missault, S., Fransen, E., et al. Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia. Behav Brain Res 258 (2014), 179–186.
122. Zhu, F., Zheng, Y., Liu, Y., Zhang, X., Zhao, J., Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic–polyribocytidilic acid. Psychiatry Res 219 (2014), 680–686.
123. Missault, S., Van den Eynde, K., Vanden Berghe, W., et al. The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain Behav Immun 42 (2014), 138–146.
124. Smolders, S., Smolders, S.M., Swinnen, N., et al. Maternal immune activation evoked by polyinosinic:polycytidylic acid does not evoke microglial cell activation in the embryo. Front Cell Neurosci, 9, 2015, 301.
125. Giovanoli, S., Weber-Stadlbauer, U., Schedlowski, M., Meyer, U., Engler, H., Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies. Brain Behav Immun 55 (2016), 25–38.
126. Patterson, P.H., Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204 (2009), 313–321.
127. Takahashi, Y., Yu, Z., Sakai, M., Tomita, H., Linking activation of microglia and peripheral monocytic cells to the pathophysiology of psychiatric disorders. Front Cell Neurosci, 10, 2016, 144.
128. Hercher, C., Chopra, V., Beasley, C.L., Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder. J Psychiatry Neurosci 39 (2014), 376–385.
129. Garey, L., When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits. J Anat 217 (2010), 324–333.
130. Prata, J., Santos, S.G., Almeida, M.I., Coelho, R., Barbosa, M.A., Bridging autism spectrum disorders and schizophrenia through inflammation and biomarkers─pre-clinical and clinical investigations. J Neuroinflammation, 14, 2017, 179.
131. Hui, C.W., St-Pierre, A., El Hajj, H., et al. Prenatal immune challenge in mice leads to partly sex-dependent behavioral, microglial, and molecular abnormalities associated with schizophrenia. Front Mol Neurosci, 11, 2018, 13.
132. Birnbaum, R., Weinberger, D.R., A genetics perspective on the role of the (neuro)immune system in schizophrenia. Schizophr Res, 2019 Mar 5 pii: S0920-9964(19)30065-9. https://doi.org/10.1016/j.schres.2019.02.005. [Epub ahead of print].
133. Pinto, J.V., Passos, I.C., Librenza-Garcia, D., et al. Neuron-glia interaction as a possible pathophysiological mechanism of bipolar disorder. Curr Neuropharmacol 16 (2018), 519–532.
134. Yirmiya, R., Rimmerman, N., Reshef, R., Depression as a microglial disease. Trends Neurosci 38 (2015), 637–658.
135. Czéh, B., Nagy, S.A., Clinical findings documenting cellular and molecular abnormalities of glia in depressive disorders. Front Mol Neurosci, 11, 2018, 56.
136. Laurence, J.A., Fatemi, S.H., Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4 (2005), 206–210.
137. Verkhratsky, A., Butt, A.M., Glial physiology and pathophysiology. 1st ed., 2013, Wiley-Blackwell, Hoboken, NJ.
138. Choudhury, P.R., Lahiri, S., Rajamma, U., Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol Biochem Behav 100 (2012), 841–849.
139. Rahn, K.A., Slusher, B.S., Kaplin, A.I., Glutamate in CNS neurodegeneration and cognition and its regulation by GCPII inhibition. Curr Med Chem 19 (2012), 1335–1345.
140. Fatemi, S.H., Folsom, T.D., Reutiman, T.J., Lee, S., Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse 62 (2008), 501–507.
141. Fatemi, S.H., Folsom, T.D., Reutiman, T.J., Sidwell, R.W., Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin. Schizophr Res 98 (2008), 163–177.
142. Wang, J., Li, Z., Feng, M., et al. Opening of astrocytic mitochondrial ATP-sensitive potassium channels upregulates electrical coupling between hippocampal astrocytes in rat brain slices. PLoS One, 8, 2013, e56605.
143. Rajkowska, G., Stockmeier, C.A., Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets 14 (2013), 1225–1236.
144. Verkhratsky, A., Parpura, V., Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders. Neurobiol Dis 85 (2016), 254–261.
145. Schwarcz, R., Hunter, C.A., Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?. Schizophr Bull 33 (2007), 652–653.
146. Wilson, E.H., Hunter, C.A., The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis. Int J Parasitol 34 (2004), 543–548.
147. Guidetti, P., Hoffman, G.E., Melendez-Ferro, M., Albuquerque, E.X., Schwarcz, R., Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry. Glia 55 (2007), 78–92.
148. Najjar, S., Pearlman, D.M., Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 161 (2015), 102–112.
149. Segal, D., Koschnick, J.R., Slegers, L.H.A., Hof, P.R., Oligodendrocyte pathophysiology: a new view of schizophrenia. Int J Neuropsychopharmacol 10 (2007), 503–511.
150. Rajkowska, G., Miguel-Hidalgo, J.J., Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6 (2007), 219–233.
151. Takahashi, N., Sakurai, T., Davis, K.L., Buxbaum, J.D., Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol 93 (2011), 13–24.
152. Konradi, C., Sillivan, S.E., Clay, H.B., Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 45 (2012), 37–47.
153. Mauney, S.A., Pietersen, C.Y., Sonntag, K.-C., Woo, T.-U.W., Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia. Schizophr Res 169 (2015), 374–380.
154. Miyata, S., Hattori, T., Shimizu, S., Ito, A., Tohyama, M., Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder. Biomed Res Int, 2015, 2015, 492367.
155. Wang, X., Rousset, C.I., Hagberg, H., Mallard, C., Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Meonatal Med 11 (2006), 343–353.
156. van Tilborg, E., Achterberg, E.J.M., van Kammen, C.M., et al. Combined fetal inflammation and postnatal hypoxia causes myelin deficits and autism-like behavior in a rat model of diffuse white matter injury. Glia 66 (2018), 78–93.
157. Carmody, D.P., Lewis, M., Regional white matter development in children with autism spectrum disorders. Dev Psychobiol 52 (2010), 755–763.
158. Graciarena, M., Seiffe, A., Nait-Oumesmar, B., Depino, A.M., Hypomyelination and oligodendroglial alterations in a mouse model of autism spectrum disorder. Front Cell Neurosci, 12, 2019, 517.
159. Cassoli, J.S., Guest, P.C., Malchow, B., Schmitt, A., Falkai, P., Martins-de-Souza, D., Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules. NPJ Schizophr, 1, 2015, 15034.
160. Maas, D.A., Vallès, A., Martens, G.J.M., Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry, 7, 2017, e1171.
161. Keshavarz, M., Glial cells as key elements in the pathophysiology and treatment of bipolar disorder. Acta Neuropsychiatr 29 (2017), 140–152.
162. Tkachev, D., Mimmack, M.L., Ryan, M.M., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362 (2003), 798–805.
163. Estes, M.L., McAllister, A.K., Maternal immune activation: Implications for neuropsychiatric disorders. Science 353 (2016), 772–777.
164. Oskvig, D.B., Elkahloun, A.G., Johnson, K.R., Phillips, T.M., Herkenham, M., Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response. Brain Behav Immun 26 (2012), 623–634.
165. Elovitz, M.A., Brown, A.G., Breen, K., Anton, L., Maubert, M., Burd, I., Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. Int J Dev Neurosci 29 (2011), 663–671.
166. Basil, P., Li, Q., Dempster, E.L., et al. Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain. Transl Psychiatry, 4, 2014, e434.
167. Mazina, V., Gerdts, J., Trinh, S., et al. Epigenetics of autism-related impairment: copy number variation and maternal infection. J Dev Behav Pediatr 36 (2015), 61–67.
168. Grayson, D.R., Guidotti, A., The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology 38 (2013), 138–166.
169. Nestler, E.J., Peña, C.J., Kundakovic, M., Mitchell, A., Akbarian, S., Epigenetic basis of mental illness. Neuroscientist 22 (2016), 447–463.
170. Jaffe, A.E., Gao, Y., Deep-Soboslay, A., et al. Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat Neurosci 19 (2016), 40–47.
171. Pidsley, R., Viana, J., Hannon, E., et al. Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia. Genome Biol, 15, 2014, 483.
172. National Institutes of Health. A scientific illustration of how epigenetic mechanisms can affect health. Available at: https://commonfund.nih.gov/epigenomics/figure, 2018. (Accessed 3 June 2019)
173. Labouesse, M.A., Dong, E., Grayson, D.R., Guidotti, A., Meyer, U., Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex. Epigenetics 10 (2015), 1143–1155.
174. Richetto, J., Massart, R., Weber-Stadlbauer, U., Szyf, M., Riva, M.A., Meyer, U., Genome-wide DNA methylation changes in a mouse model of infection-mediated neurodevelopmental disorders. Biol Psychiatry 81 (2017), 265–276.
175. Lipina, T.V., Zai, C., Hlousek, D., Roder, J.C., Wong, A.H., Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J Neurosci 33 (2013), 7654–7666.
176. Abazyan, B., Nomura, J., Kannan, G., et al. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68 (2010), 1172–1181.
177. Louie, J.K., Acosta, M., Jamieson, D.J., Honein, M.A., Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 362 (2010), 27–35.
178. Pfitscher, L.C., Cecatti, J.G., Pacagnella, R.C., et al. Severe maternal morbidity due to respiratory disease and impact of 2009 H1N1 influenza A pandemic in Brazil: results from a national multicenter cross-sectional study. BMC Infect Dis, 16, 2016, 220.
179. Nunes, M.C., Madhi, S.A., Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: a systematic review and meta-analysis. Hum Vaccines Immunother 14 (2017), 758–766.
180. Shakib, J.H., Korgenski, K., Presson, A.P., et al. Influenza in infants born to women vaccinated during pregnancy. Pediatrics, 137, 2016, e20152360.
181. Marshall, H., Mcmillan, M., Andrews, R.M., Macartney, K., Edwards, K., Vaccines in pregnancy: the dual benefit for pregnant women and infants. Hum Vaccin Immunother 12 (2016), 848–856.
182. Zaman, K., Roy, E., Arifeen, S.E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 (2008), 1555–1564.
183. Madhi, S.A., Cutland, C.L., Kuwanda, L., et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 371 (2014), 918–931.
184. World Health Organization. Vaccines against Influenza WHO Position Paper─November 2012. Available at: https://www.who.int/immunization/position_papers/PP_influenza_november2012_summary.pdf. Accessed July 23, 2019.
185. Kahn, K.E., Black, C.L., Ding, H., et al. Influenza and Tdap vaccination coverage among pregnant women─United States, April 2018. MMWR Morb Mortal Wkly Rep 67 (2018), 1055–1059.
186. Centers for Disease Control and Prevention NC for I and RD (NCIRD). Flu vaccination coverage among pregnant women─United States, 2015-16 flu season. Atlanta, GA: Centers for Disease Control and Prevention.
187. Yuet, C., Yuen, S., Tarrant, M., Determinants of uptake of influenza vaccination among pregnant women─a systematic review. Vaccine 32 (2014), 4602–4613, 10.1016/j.vaccine.2014.06.067.
188. European Centre for Disease Prevention and Control. Seasonal influenza vaccination and antiviral use in EU/EEA Member States. 2018, European Centre for Disease Prevention and Control, Stockholm.
189. Kharbanda, E.O., Vazquez-Benitez, G., Romitti, P.A., et al. First trimester influenza vaccination and risks for major structural birth defects in offspring. J Pediatr 187 (2017), 234–239.
190. Sperling, R.S., Riley, L.E., Group on behalf of TI and EIEW. Influenza vaccination, pregnancy safety, and risk of early pregnancy loss. Obstet Gynecol 131 (2018), 799–802.
191. Sheffield, J.S., Greer, L.G., Rogers, V.L., et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol 120 (2012), 532–537.
192. Tamma, P.D., Ault, K.A., del Rio, C., Steinhoff, M.C., Halsey, N.A., Omer, S.B., Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 201 (2009), 547–552.
193. Bednarczyk, R.A., Adjaye-Gbewonyo, D., Omer, S.B., Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol 207 (2012), S38–S46.
194. Chambers, C.D., Johnson, D.L., Xu, R., et al. Safety of the 2010–11, 2011–12, 2012–13, and 2013–14 seasonal influenza vaccines in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants; a study from the cohort arm of VAMPSS. Vaccine 34 (2016), 4443–4449.
195. Macias, A.E., Precioso, A.R., Falsey, A.R., Initiative, G.I., The Global Influenza Initiative recommendations for the vaccination of pregnant women against seasonal influenza. Influenza Other Respir Viruses 9:Suppl 1 (2015), 31–37.
196. Mak, T.K., Mangtani, P., Leese, J., Watson, J.M., Pfeifer, D., Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 8 (2008), 44–52.
197. Centers for Disease Control and Prevention. Measles. Available at: https://www.cdc.gov/measles/cases-outbreaks.html. Accessed July 4, 2019.
198. Rasmussen, S.A., Jamieson, D.J., What obstetric health care providers need to know about measles and pregnancy. Obstet Gynecol 126 (2015), 163–170.
199. Manikkavasagan, G., Ramsay, M., The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review. J Obstet Gynaecol (Lahore) 29 (2009), 572–575.
200. Atmar, R.L., Englund, J.A., Hammill, H., Complications of measles during pregnancy. Clin Infect Dis 14 (1992), 217–226.
201. Mclean, H.Q., Fiebelkorn, A.P., Temte, J.L., Wallace, G.S., Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 62 (2013), 1–34.
202. World Health Organization. Malaria in pregnant women. Available at: https://www.who.int/malaria/areas/high_risk_groups/pregnancy/en/, 2017. (Accessed 22 April 2019)
203. Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD). Build a Zika prevention kit. Available at: https://www.cdc.gov/zika/prevention/prevention-kit.html, 2019. (Accessed 22 April 2019)
204. Centers for Disease Control and Prevention. Zika travel information. Available at: https://wwwnc.cdc.gov/travel/page/zika-travel-information. Accessed July 4, 2019.
205. WHO Global Malaria Programme, WHO Department of Reproductive Health and Research. WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). 2014, World Health Organization, Geneva.
206. Szweda, H., Jozwik, M., Urinary tract infections during pregnancy─an updated overview. Dev Period Med 20 (2016), 263–272.
207. Millar, L.K., Cox, S.M., Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 11 (1997), 13–26.
208. Easter, S.R., Cantonwine, D.E., Zera, C.A., Lim, K.-H., Parry, S.I., McElrath, T.F., Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia. Am J Obstet Gynecol, 214, 2016, 387.
209. Fichorova, R.N., Beatty, N., Sassi, R.R.S., et al. Systemic inflammation in the extremely low gestational age newborn following maternal genitourinary infections. Am J Reprod Immunol 73 (2015), 162–174.
210. Ahlin, K., Himmelmann, K., Hagberg, G., et al. Cerebral palsy and perinatal infection in children born at term. Obstet Gynecol 122 (2013), 41–49.
211. Humann, J., Mann, B., Gao, G., et al. Bacterial peptidoglycan traverses the placenta to induce fetal neuroproliferation and aberrant postnatal behavior. Cell Host Microbe 19 (2016), 388–399.
212. Lanté, F., Meunier, J., Guiramand, J., et al. Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus 18 (2008), 602–609.
213. De Felice, M., Melis, M., Aroni, S., et al. The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. CNS Neurosci Ther 25 (2019), 549–561.
214. Ma, M., Ren, Q., Yang, J., et al. Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation. Proc Natl Acad Sci 116 (2019), 7083–7088.
215. Wang, Q., Liu, C., Protective effects of quercetin against brain injury in a rat model of lipopolysaccharide-induced fetal brain injury. Int J Dev Neurosci 71 (2018), 175–180.
216. Kalmady, S.V., Venkatasubramanian, G., Shivakumar, V., et al. Relationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naive schizophrenia: evidence for differential susceptibility?. PLoS One, 9, 2014, e96021.
217. Xuan, I.C.Y., Hampson, D.R., Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PLoS One, 9, 2014 e104433-e104433.
218. Bronson, S.L., Bale, T.L., Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment. Endocrinology 155 (2014), 2635–2646.
219. Mann, J.R., McDermott, S., Are Maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children?. J Atten Disord 15 (2010), 667–673.
220. Werenberg Dreier, J., Nybo Andersen, A.-M., Hvolby, A., Garne, E., Kragh Andersen, P., Berg-Beckhoff, G., Fever and infections in pregnancy and risk of attention deficit/hyperactivity disorder in the offspring. J Child Psychol Psychiatry 57 (2016), 540–548.
221. Kim, S., Kim, H., Yim, Y.S., et al. Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature 549:7673 (2017), 528–532.
222. Osokine, I., Erlebacher, A., Inflammation and autism: from maternal gut to fetal brain. Trends Mol Med 23 (2017), 1070–1071.
223. Stiles, J., Jernigan, T.L., The basics of brain development. Neuropsychol Rev 20 (2010), 327–348.